More US FDA Enforcement Of Clinical Trial Reporting Is Expected After Acceleron’s ‘Clerical Oversight’

 
• By Brenda Sandburg
  
clinicaltrials.gov
Acceleron is the first company cited for failure to report trial results on ClinicalTrials.gov • Source: Alamy

More from Clinical Trials

More from R&D